NCT00260611View on ClinicalTrials.gov

Study of Oxaliplatin and Taxotere in Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Prostate Cancer

Interventions

DRUG

Oxaliplatin

DRUG

Taxotere

Trial Locations (1)

15232

Hillman Cancer Center, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

University of Pittsburgh

OTHER